Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Author: Ramyashree Narayana*, Shivprasad Sanjay Dhage
Format: Recurso digital
Language:
Published: Zenodo 2026
Subjects:
epigenetics; DNA methylation; histone modification; HDAC inhibitors; DNMT inhibitors; cardiac hypertrophy; myocardial fibrosis; heart failure; CpG islands; chromatin remodelling; non-coding RNA; epigenetic biomarkers; BET inhibitors; EZH2; cardiovascular physiology.
Online Access:https://doi.org/10.5281/zenodo.19641350
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://doi.org/10.5281/zenodo.19641350

Similar Items

  • Epigenetics Communications
    Published: (2022)
  • EVALUATION OF THE EFFICACY OF SGLT2 INHIBITOR THERAPY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
    by: Cotoneț, Tatiana, et al.
    Published: (2025)
  • Epigenetics Reports
    Published: (2025)
  • CHRONIC HEART FAILURE: MODERN DIAGNOSTIC AND THERAPEUTIC APPROACHES
    by: Salohiddinova Hojaroy, et al.
    Published: (2025)
  • Figure 2 from: Sammor MS, Habashneh AY, Al-Sha'er MA, Bardaweel SK, El‐Abadelah MM (2025) Novel spirooxindole compounds as anticancer agents: targeting Plk4 kinase through design, synthesis, and molecular docking. Pharmacia 72: 1-13. https://doi.org/10.3897/pharmacia.72.e149240
    by: Sammor, Mervat S., et al.
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs